Evidence map›Paper›PMID 34434862›Full record

ArticleMethodsX2021

Categorizing microbial growth inhibition through quantification of 16S rRNA growth marker with stripwells covering a spectrum of antimicrobial conditions.

Jade Chen, Michael Tomasek, Vincent Gau

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in MethodsX, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jade ChenGeneFluidics, Irwindale, California, USA.
Michael TomasekGeneFluidics, Irwindale, California, USA.
Vincent GauGeneFluidics, Irwindale, California, USA.
GeneFluidics (United States) · US

Funding

Safe and Effective Whole Blood ID/AST Device for Use in Neonatal ICU SettingsR44HD084033 · NICHD · GENEFLUIDICS, INC. · PI GAU, VINCENT JEN-JR · 2015 to 2021
$4.6M
A fully integrated CentriFluidic system for direct bloodstream infection PID/ASTR01AI117059 · NIAID · GENEFLUIDICS, INC. · PI GAU, VINCENT JEN-JR · 2015 to 2019
$3.6M
Near patient molecular diagnostics test for infectionsSB1AI088756 · NIAID · GENEFLUIDICS, INC. · PI GAU, VINCENT JEN-JR · 2016 to 2018
$3.0M
NIAID NIH HHS R01 AI117059NIAID NIH HHS SB1 AI088756NICHD NIH HHS R44 HD084033
6 · The paper itself

Abstract

Culture-based microdilution and disk diffusion tests are two commonly used reference methods for determining the susceptibility of causative bacteria to antibiotics. However, these methods are slow and laborious. Automated antimicrobial susceptibility test (AST) instruments are extensively used in clinical microbiology labs, replacing manual methods to perform gold standard microdilution or disk diffusion methods. These automated instruments require the use of isolated bacteria grown in pure culture against a fixed antimicrobial panel, and the susceptibility tests are based on measuring bacterial growth or turbidity changes over a range of pre-determined antimicrobial conditions. As a result, these automated technologies remain inherently inflexible to frequent adjustment of minimum inhibitory concentrations published by the Clinical and Laboratory Standards Institute and are limited by the detection methods that consumables were designed for. Here, we present a stripwell that is compatible with the 96-well format of most lab automation systems to provide a streamlined workflow to inoculate microorganisms for a customized or routine AST. The main goal of this method of stripwell preparation with various antibiotic conditions is to enable the utility of lab automation for phenotypic antibiotic response assays to address the reproducibility issues due to manual operation. • A standardized and scalable solution from inoculation to antimicrobial incubation • Microplates in stripwell format offer the advantage of greater flexibility in clinical microbiology and diagnostics • Customized antimicrobials and dilution ranges tailored to unique specifications for research and development.

Indexed as

1 × 8 stripwell96-well plate format96-well standard heating blockAST, antimicrobial susceptibility testingCLSI, Clinical and Laboratory Standards InstituteCustomized antimicrobialsCustomized dilution rangesDEPC, Diethyl pyrocarbonateMIC, minimum inhibitory concentrationScalable antibiotic incubation

Identifiers

PMID34434862
PMCPMC8374695
OpenAlexW3177875596

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.